APOF and chronic kidney disease: The fourth set included proteins with altered abundance in both CKD and CVDpatients compared with HVs but with differences between CKD and CVD patients.Large differences, especially between CKD5 and CVD patients, were visible whencomparing the accumulation of apoB, apoCI, apoCIII, apoF, apoH, and lipoproteina (LPa).